Pharmabiz

Orchestra BioMed enrols first patients in Virtue SAB pivotal investigational device exemption coronary trial

Orchestra BioMed enrols first patients in Virtue SAB pivotal investigational device exemption coronary trial: New Hope, Pennsylvania Wednesday, October 29, 2025, 18:00 Hrs [IST] O ...
Pharmabiz

Ajinomoto Bio-Pharma & Olon S.p.A. form strategic partnership to advance large-scale peptide and protein manufacturing

Ajinomoto Bio-Pharma & Olon S.p.A. form strategic partnership to advance large-scale peptide and protein manufacturing: Tokyo, Japan Wednesday, October 29, 2025, 17:00 Hrs [IST] A ...
Pharmabiz

Salesforce India debuts Agentforce Life Sciences to drive customer engagement and alleviate doctor burnout

Salesforce India debuts Agentforce Life Sciences to drive customer engagement and alleviate doctor burnout: Our Bureau, Bengaluru Wednesday, October 29, 2025, 16:30 Hrs [IST] Sale ...
Pharmabiz

SMT’s Supraflex Cruz shows consistent and robust clinical outcomes

SMT’s Supraflex Cruz shows consistent and robust clinical outcomes: Our Bureau, Mumbai Wednesday, October 29, 2025, 16:15 Hrs [IST] Sahajanand Medical Technologies (SMT), a medi ...
Pharmabiz

EMA grants Orphan Drug Designation to GSK’s B7-H3-targeted antibody-drug conjugate, GSK’227 to treat pulmonary neuroendocrine carcinoma

EMA grants Orphan Drug Designation to GSK’s B7-H3-targeted antibody-drug conjugate, GSK’227 to treat pulmonary neuroendocrine carcinoma: London, UK Wednesday, October 29, 2025 ...
Pharmabiz

First UK patient with multiple sclerosis treated with CAR T cell therapy

First UK patient with multiple sclerosis treated with CAR T cell therapy: United Kingdom Wednesday, October 29, 2025, 15:00 Hrs [IST] A patient with multiple sclerosis has become ...
Pharmabiz

Ramaiah Memorial Hospital underscores need for bone health & osteoporosis diagnosis through advanced DXA scanner

Ramaiah Memorial Hospital underscores need for bone health & osteoporosis diagnosis through advanced DXA scanner: Our Bureau, Bengaluru Wednesday, October 29, 2025, 14:45 Hrs [IST ...
Pharmabiz

Metropolis Healthcare study reveals 46% of tested individuals show vitamin D deficiency across India

Metropolis Healthcare study reveals 46% of tested individuals show vitamin D deficiency across India: Our Bureau, Bengaluru Wednesday, October 29, 2025, 14:30 Hrs [IST] Metropolis ...
Pharmabiz

Alembic Pharmaceuticals receives US FDA final approval for ticagrelor tablets, 60 mg

Alembic Pharmaceuticals receives US FDA final approval for ticagrelor tablets, 60 mg: Our Bureau, Bengaluru Wednesday, October 29, 2025, 14:15 Hrs [IST] Alembic Pharmaceuticals Li ...
Pharmabiz

Philips introduces industry-first cath lab integration; paving the way for CT-guided PCI

Philips introduces industry-first cath lab integration; paving the way for CT-guided PCI: San Francisco Wednesday, October 29, 2025, 14:00 Hrs [IST] Royal Philips, a global leader ...
Pharmabiz

Supernus Pharma to buy CNS portfolio from US WorldMeds

Supernus Pharma to buy CNS portfolio from US WorldMeds Rockville, Maryland Thursday, April 30, 2020, 11:00 Hrs [IST] Supernus Pharmaceuticals, Inc., a pharmaceutical company focused on developing and ...
Pharmabiz

Merck & Eisai announce Welireg plus Lenvima meets primary endpoint of PFS in certain previously treated patients with advanced RCC

Merck & Eisai announce Welireg plus Lenvima meets primary endpoint of PFS in certain previously treated patients with advanced RCC: Rahway, New Jersey Wednesday, October 29, 2025, ...